Inhibition of murine AIDS by reduced glutathione

AIDS Research and Human Retroviruses

Volumn 12, Issue 14, 1996, Pages 1373-1381

  Palamara, Anna T ^a   Garaci, Enrico ^a   Rotilio, Giuseppe ^a   Ciriolo, Maria R ^b   Casabianca, Anna ^c   Fraternale, Alessandra ^c   Rossi, Luigia ^c   Schiavano, Giuditta F ^c   Chiarantini, Laura ^c   Magnani, Mauro ^c  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c UNIVERSITY OF URBINO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL FEATURE; CONCENTRATION RESPONSE; DNA CONTENT; DRUG MEGADOSE; HYPERGAMMAGLOBULINEMIA; LYMPHADENOPATHY; MOUSE; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; RODENT DISEASE; SPLENOMEGALY;

EID: 0029793861     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1996.12.1373     Document Type: Article

References (29)

1. Staal FJT, Stephen WE, Roederer M, Anderson MT, Herzenberg LA, and Herzenberg LA: Gutathione deficiency and human immunodeficiency virus infection. Lancet 1992;339:909-912.
2. Pace GW, and Leaf CD: The role of oxidative stress in HIV disease. Free Radic Biol Med 1995;19:523-528.
3. Buhl R, Jaffe HA, Holroyd KJ, Wells FB, Mastrangeli A, Saltini C, Cantin AM, and Crystal RG: Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. Lancet 1989;2: 1294-1298.
4. Meister A: Glutathione metabolism and its selective modification. J Biol Chem 1988;263:17205-17208.
5. Staal FJ, Roederer M, Herzenberg LA, and Herzenberg LA: Intracellular thiols regulate activation of nuclear factor KB and transcription of human immunodeficiency virus. Proc Natl Acad Sci USA 1990;87:9943-9947.
6. + cells. FASEB J 1994;8:448-451.
7. Mihm S, Gaiter D, and Droge W: Modulation of transcription factor NF-κB activity by intracellular glutathione levels and by variations of the extracellular cysteine supply. FASEB J 1995;9: 246-252.
8. Suthanthiran M, Anderson ME, Sharma VK, and Meister A: Glutathione regulates activation-dependent DNA synthesis in highly purified normal human T lymphocytes stimulated via the CD2 and CD3 antigens. Proc Natl Acad Sci USA 1990;87: 3343-3347.
9. Kalebic T, Kinter A, Poli G, Anderson ME, Meister A, and Fauci AS: Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester, and N-acetylcysteine. Proc Natl Acad Sci USA 1991;88: 986-990.
10. Roederer M, Staal FJT, Raju PA, Ela SW, Herzenberg LA, and Herzenberg LA: N-Acetylcysteine inhibits latent HIV expression in chronically infected cells. AIDS Res Hum Retroviruses 1991;7:563-567.
11. Palamara AT, Perno C-F, Ciriolo MR, Dini L, Balestra E, D'Agostini C, Di Francesco P, Favalli C, Rotilio G, and Garaci E: Evidence for antiviral activity of glutathione: In vitro inhibition of herpes simplex virus type 1 replication. Antiv Res 1995;27:237-253.
12. Morse III HC, Chattopadhyay SK, Makino M, Fredrickson TN, Hügin AW, and Hartley JW: Retrovirus-induced immunodeficiency in the mouse: MAIDS as a model for AIDS. AIDS 1992;6:607-621.
13. Jolicoeur P: Murine acquired immunodeficiency syndrome (MAIDS): An animal model to study the AIDS pathogenesis. Faseb J 1991;5:2398-2405.
14. Mosier DE, Yetter RA, and Morse HC III: Functional T lymphocytes are required for a murine retrovirus induced immunodeficiency disease (MAIDS). J Exp Med 1987;165:1737-1742.
15. Beutler E: A manual of biochemical methods. In Red Cell Metabolism. Grune & Stratton, New York, 1975, pp. 131-134.
16. Brandi G, Casablanca A, Schiavano GF, Rossi L, Fratemale A, Albano A, and Magnani M: Efficacy and toxicity of long-term administration of 2′,3′-dideoxycytidine in the LP-BM5 murine-induced immunodeficiency model. Antiv Chem Chemother 1995;6(3):153-161.
17. Chattopadhyay SK, Sengupta DN, Fredrickson TN, Morse HC III, and Hartely JW: Characteristic and contributions of defective, ecotropic and mink cell focus-inducing viruses in a retrovirus induced immunodeficiency syndrome of mice. J Virol 1991;65:4232-4241.
18. Kurdi-Haidar B, Mason PJ, Berrebi A, Ankra-Bodu G, Al-Ali A, Oppemheim A, and Luzzatto L: Origin and spread of the glucose-6-phosphate dehydrogenase variant (G6PD-Mediterranean) in the Middle east. Am J Hum Genet 1990;47:1013-1019.
19. Magnani M, Casabianca A, Rossi L, Fraternale A, Brandi G, Silvotti L, and Piedimonte G: Inhibition of HIV-1 and LP-BM5 replication in macrophages by dideoxycytidine and dideoxycytidine 5′-triphosphate. Antiv Chem Chemother 1995;6(5):312-319.
20. Garaci E, Palamara AT, Di Francesco P, Favalli C, Ciriolo MR, and Rotilio G: Glutathione inhibits replication and expression of viral proteins in cultured cells infected with Sendai virus. Biochem Biophys Res Commun 1992;188:1090-1096.
21. Klinken SP, Fredrickson TN, Hartley JW, Yetter RA, and Morse HC III: Evolution of B cell lineage lymphomas in mice with a retrovirus-induced immunodeficiency syndrome, MAIDS. J Immunol 1988;140:1737-1742.
22. Levacher-Clergeot F, Chau M, Desforges B, Ricatte L, and Sinet M: Prognostic value of phenotypic alterations in blood lymphocyte subsets in a murine retrovirus-induced immunodeficiency syndrome (MAIDS). Clin Exp Immunol 1993;91:467-472.
23. Fraternale A, Casabianca A, Rossi L, Chiarantini L, Brandi G, Aluigi G, Schiavano GF, and Magnani M: Inhibition of murine AIDS by combination of AZT and dideoxycytidine 5′-triphosphate. J. AIDS 1996;12:164-173.
24. De Quay B, Malinversi R, and Lauterburg BH: Glutathione depletion in HIV-infected patients: Role of cysteine deficiency and effect of oral N-acetylcysteine. AIDS 1992;6:815-819.
25. Buhl R: Imbalance between oxidants and antioxidants in the lungs of HIV-seropositive individuals. Chem Biol Interact 1994;91: 147-158.
26. + lymphocytes associated with disturbed intracellular redox balance in human immunodeficiency virus type 1 infection. Blood 1995;86:258-267.
27. Witschi A, Junker E, Schranz C, Speck RF, and Lauterburg BH: Supplementation of N-acetylcysteine fails to increase glutathione in lymphocytes and plasma of patients with AIDS. AIDS Res Hum Retroviruses 1995;11:141-143.
28. Yoshimao K, Yoshiaki N, Kazuhiro K, Hirobiko M, Michihiro I, Kagemasa K, Toru M, Hiroshi H, Toshiyasu H, Shin-Ichi Y, and Ishimoto A: Presence of transplantable T-lymphoid cells in C57BL/6 mice infected with murine AIDS virus. J Virol 1992;66:5691-5695.
29. Wan Kee K, Yao T, James JK, Dan LL, and Morse III HC: In murine AIDS, B cells are early targets of defective virus and are required for efficient infection and expression of defective virus in T cells and macrophages. J. Virol. 1994;68:6767-6769.